Enanta Pharmaceutica (ENTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 55,095 | 87,131 | 99,855 | 74,338 | 27,558 |
| Marketable Securities | 331,101 | 299,518 | 270,145 | 280,917 | 346,227 |
| Receivables | 31,743 | 36,533 | 18,653 | 27,619 | 52,570 |
| TOTAL | $445,942 | $436,837 | $413,381 | $402,709 | $440,508 |
| Non-Current Assets | |||||
| PPE Net | 7,788 | 8,596 | 9,285 | 9,738 | 10,407 |
| Investments And Advances | 18,462 | 32,634 | 65,404 | 80,099 | 40,941 |
| Other Non-Current Assets | 8,820 | 8,065 | 23,634 | 20,955 | 19,118 |
| TOTAL | $35,070 | $49,295 | $98,323 | $110,792 | $70,466 |
| Total Assets | $481,012 | $486,132 | $511,704 | $513,501 | $510,974 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,305 | 5,737 | 6,074 | 5,945 | 6,596 |
| Accrued Expenses | 11,542 | 14,159 | 13,576 | 9,807 | 9,411 |
| TOTAL | $23,044 | $24,157 | $23,914 | $19,516 | $19,139 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 5,973 | 6,395 | 7,233 | 7,994 | 9,548 |
| TOTAL | $5,973 | $6,395 | $7,233 | $7,994 | $9,548 |
| Total Liabilities | $29,017 | $30,552 | $31,147 | $27,510 | $28,687 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 20,172 | 20,079 | 20,072 | 20,004 | 19,924 |
| Common Shares | 201 | 201 | 201 | 200 | 198 |
| Retained earnings | 119,244 | 127,572 | 156,913 | 171,178 | 177,183 |
| Other shareholders' equity | 405 | 844 | 1,458 | 608 | 234 |
| TOTAL | $451,995 | $455,580 | $480,557 | $485,991 | $482,287 |
| Total Liabilities And Equity | $481,012 | $486,132 | $511,704 | $513,501 | $510,974 |